Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

The B100 Method Brings Heart Disease Prevention to the Comfort of Your Home

A Cardiologist in Your Pocket - Detecting Heart Disease up to 15 Years Early


News provided by

B100

Feb 10, 2022, 09:30 ET

Share this article

Share toX

Share this article

Share toX

www.b100method.com
www.b100method.com

BEVERLY HILLS, Calif., Feb. 10, 2022 /PRNewswire-PRWeb/ -- Launching today in the midst of American Heart Month is the B100 Method, an innovative, groundbreaking tool assisting in the prevention of heart disease. This one-of-a-kind, at-home heart test is driven by sophisticated data, up-to-the-minute science, and is backed by well-known Beverly Hills cardiologist Dr. Arash Bereliani who has more than 20 years of clinical practice insights. Dr. Bereliani describes the B100 home test as easy, painless, and comprehensive. While this test is not designed to replace your cardiologist, B100 will place you at the helm of advocacy for your own heart health from the convenience of your home.

"B100 fills a much-needed market niche as the only home-based solution that directly addresses the heart health epidemic," remarks Dr. Bereliani, co-founder of the B100 Method. "This home test is designed in a way that can assess your heart disease risk in the next 10-15 years, providing immediate, actionable steps to improve your risk factors."

“Just as DNA genetic testing is synonymous with genealogy, B100 will be synonymous with heart disease prevention,” says Dr. Bereliani. “This is the future of cardiology.”

Post this

According to the CDC, 659,000 people in the United States die from heart disease each year (that's 1 in every 4 deaths) and one person dies every 36 seconds in the USA from cardiovascular disease. Heart disease remains, by far, the nation's #1 killer and most costly disease, but it is also preventable. Over the past two years, many have put off seeing doctors and specialists due to the global pandemic. This delay is driving heart disease back to the forefront of our attention as much needed heart health tests are skipped or come too late. What is the preventative solution for heart disease? The B100 Method.

The B100 Method home test is easy with three simple steps from start to finish:

1. Provide Your Information; Including an Online Quiz Assessment, Blood Pressure, Body Measurements, and Nitric Oxide: The quiz takes only 10 minutes to complete, with questions pertaining to your lifestyle and family history that will provide deep insight into your heart health. Body measurements will guide B100 in how your body mass is distributed, while the nitric oxide saliva test will evaluate if levels are within the range for heart healthy conditions. Up to 4 Blood Pressure readings will provide a more detailed picture than a single reading in a Dr's office can.

2. Collect and Return Your Sample for Professional Lab Work: The blood sample is easy and painless, with no needles required, and uses a patented, FDA-approved blood collection device (not a finger prick!). B100 provides the most advanced cardiac lab panel available, more in depth than those checked by most doctors. Mail the samples back to the lab for processing in the provided prepaid envelope.

3. Receive and Read Your Results: B100 will evaluate the provided information and lab results against its overall database, and use the proprietary B100 algorithm to generate a "LubDub" grade (your heart's sound), which can range from an A, indicating very low risk for developing heart disease, to a D which tells you that you are at high risk for heart disease and should be under the care of a cardiologist. A cardiologist in your area can be recommended if you don't already have one.

Along with your LubDub grade, you will also receive comprehensive information from your home test results and suggestions from Dr. Bereliani regarding your next steps to optimize your heart health. The provided recommendations are extremely thorough and will provide a step-by-step analysis of each factor that is a risk for you personally, based on your test results.

The B100 Method is a natural addition to your regular doctor visits that goes beyond the typical testing done at the doctor's office and more accurately predicts heart disease risk. The B100 Method also offers additional extended testing and home health options, including genetic marker tests and a range of supplements.

"Just as DNA genetic testing is synonymous with genealogy, B100 will be synonymous with heart disease prevention," says Dr. Bereliani. "This is the future of cardiology."

You can order the B100 Method Home Test today and the test should arrive directly into your mailbox in less than 7-10 business days.

MORE ABOUT B100:

B100 fills a much-needed market niche as the only home-based solution that directly addresses the crucial heart health epidemic. We are driven by sophisticated data, up-to-the-minute science, and backed by a well-known cardiologist with over 20 years of clinical practice insights. B100 will be the heart health leader of digital healthcare and the only brand consumers should trust with their hearts at home. You can find us on Facebook and Instagram.

Media Contact

Chris Powell, Chris Powell PR, Inc., +1 4153102357, [email protected]

SOURCE B100

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.